Transcript
Page 1: Personalized Medicine and Model Based Drug Development Opportunities for Biomedical Informatics

Personalized Medicine and Model Based Drug Development Opportunities for Biomedical

Informatics

Zhachui (John) Cai, MD, PhDDirector, Biomedical Informatics

AstraZenecaPharmaceuticalsDelaware Chapter ASA Dinner Meeting

March 18, 2010

Page 2: Personalized Medicine and Model Based Drug Development Opportunities for Biomedical Informatics
Page 3: Personalized Medicine and Model Based Drug Development Opportunities for Biomedical Informatics
Page 4: Personalized Medicine and Model Based Drug Development Opportunities for Biomedical Informatics
Page 5: Personalized Medicine and Model Based Drug Development Opportunities for Biomedical Informatics
Page 6: Personalized Medicine and Model Based Drug Development Opportunities for Biomedical Informatics
Page 7: Personalized Medicine and Model Based Drug Development Opportunities for Biomedical Informatics
Page 8: Personalized Medicine and Model Based Drug Development Opportunities for Biomedical Informatics
Page 9: Personalized Medicine and Model Based Drug Development Opportunities for Biomedical Informatics

Top Related